Search Results - "Kossari, Niloufar"

Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells from End-Stage Renal Disease Patients by Peraldi, Marie-Noelle, Berrou, Jeannig, Dulphy, Nicolas, Seidowsky, Alexandre, Haas, Philippe, Boissel, Nicolas, Metivier, Fabien, Randoux, Christine, Kossari, Niloufar, Guerin, Alain, Geffroy, Sylvie, Delavaud, Guy, Marin-Esteban, Viviana, Glotz, Denis, Charron, Dominique, Toubert, Antoine

“…To characterize the immune defect of patients with end-stage renal disease (ESRD), we performed NK cell subset analysis in 66 patients with ESRD treated by…”
Get full text

Is 3-Compartment Bioimpedance Spectroscopy Useful to Assess Body Composition in Renal Transplant Patients? by Pellé, Gaëlle, MD, Branche, Isabelle, MD, Kossari, Niloufar, MD, Tricot, Leila, MD, Delahousse, Michel, MD, Dreyfus, Jean-François, MD, PhD

“…Background Metabolic disorders, in particular weight gain, increase cardiovascular mortality risk and can cause serious problems after renal transplantation…”
Get full text

Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities by Roohvand, Farzin, Kossari, Niloufar

“…Developing a vaccine against HCV is an important medical and global priority. Unavailability and potential dangers associated with using attenuated HCV viral…”
Get more information

Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design by Roohvand, Farzin, Kossari, Niloufar

“…Around 3% of the world population is infected with HCV, with 3 - 4 million newly infected subjects added to this reservoir every year. At least 10% of these…”
Get more information

Biomedical applications of yeasts - a patent view, part two: era of humanized yeasts and expanded applications by Roohvand, Farzin, Ehsani, Parastoo, Abdollahpour-Alitappeh, Meghdad, Shokri, Mehdi, Kossari, Niloufar

“…Yeast humanization, ranging from a simple point mutation to substitution of yeast gene(s) or even a complete pathway by human counterparts has enormously…”
Get more information

Bioreactance: A new tool for cardiac output and thoracic fluid content monitoring during hemodialysis by KOSSARI, Niloufar, HUFNAGEL, Gilles, SQUARA, Pierre

“…Outpatient hemodialysis therapy (HD) can be associated with hemodynamic compromise. Bioreactance® has recently been shown to provide accurate, noninvasive,…”
Get full text

Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus by ALBANO, Laetitia, BERTHOUX, François, BAYLE, François, FRANCOIS WESTEEL, Pierre, GLOTZ, Denis, KOSSARI, Niloufar, LEFRANCOIS, Nicole, CHARPENTIER, Bernard, BLANC, Anne-Sandrine, DI GIAMBATTISTA, Fabienne, DANTAL, Jacques, MOAL, Marie-Christine, ROSTAING, Lionel, LEGENDRE, Christophe, GENIN, Robert, TOUPANCE, Olivier, MOULIN, Bruno, MERVILLE, Pierre, REROLLE, Jean-Philippe

“…Concerns about delayed graft function (DGF) and wound healing complications with sirolimus has led to suggestions that everolimus introduction could be delayed…”
Get full text

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial by Dantal, Jacques, Berthoux, François, Moal, Marie-Christine, Rostaing, Lionel, Legendre, Christophe, Genin, Robert, Toupance, Olivier, Moulin, Bruno, Merville, Pierre, Rerolle, Jean-Philippe, Bayle, François, Westeel, Pierre François, Glotz, Denis, Kossari, Niloufar, Lefrançois, Nicole, Charpentier, Bernard, Quéré, Stéphane, Di Giambattista, Fabienne, Cassuto, Elisabeth

“…Immediate or early use of proliferation signal inhibitor (PSI)/mammalian target of rapamycin (mTOR) inhibitor therapy can avoid high exposure to calcineurin…”
Get more information

Effects of atorvastatin on dyslipidaemia in uraemic patients on peritoneal dialysis by Hufnagel, Gilles, Michel, Catherine, Vrtovsnik, François, Queffeulou, Guillaume, Kossari, Niloufar, Mignon, Françoise

“…Background. Our purpose was to evaluate the efficacy and safety of atorvastatin, a potent cholesterol‐ and triglyceride‐lowering agent, in peritoneal dialysis…”
Get full text